Trial Profile
Clinical trials of 18-methoxycoronaridine [18-MC] for obesity and other forms of compulsive behaviour
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 10 Jan 2013
Price :
$35
*
At a glance
- Drugs Zolunicant (Primary)
- Indications Obesity; Obsessive-compulsive disorders
- Focus Adverse reactions
- Sponsors Savant HWP
- 10 Jan 2013 New trial record